Does NIVOLUMAB Cause Haemoglobin decreased? 253 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 253 reports of Haemoglobin decreased have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.3% of all adverse event reports for NIVOLUMAB.
253
Reports of Haemoglobin decreased with NIVOLUMAB
0.3%
of all NIVOLUMAB reports
48
Deaths
146
Hospitalizations
How Dangerous Is Haemoglobin decreased From NIVOLUMAB?
Of the 253 reports, 48 (19.0%) resulted in death, 146 (57.7%) required hospitalization, and 17 (6.7%) were considered life-threatening.
Is Haemoglobin decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 253 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Haemoglobin decreased?
LENALIDOMIDE (4,031)
RUXOLITINIB (3,297)
ECULIZUMAB (3,028)
ADALIMUMAB (2,459)
CLOZAPINE (2,396)
RITUXIMAB (1,803)
APIXABAN (1,779)
NIRAPARIB (1,759)
METHOTREXATE (1,754)
RIBAVIRIN (1,753)
Which NIVOLUMAB Alternatives Have Lower Haemoglobin decreased Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE